These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16579020)

  • 1. Breast cancer screening in Canada: a review.
    Wadden N; Doyle GP
    Can Assoc Radiol J; 2005 Dec; 56(5):271-5. PubMed ID: 16579020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer screening in 21 countries: delivery of services, notification of results and outcomes ascertainment.
    Ballard-Barbash R; Klabunde C; Paci E; Broeders M; Coleman EA; Fracheboud J; Bouchard F; Rennert G; Shapiro S
    Eur J Cancer Prev; 1999 Oct; 8(5):417-26. PubMed ID: 10548397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of screening mammography in organized programs in Canada in 1996. The Database Management Subcommittee to the National Committee for the Canadian Breast Cancer Screening Initiative.
    Paquette D; Snider J; Bouchard F; Olivotto I; Bryant H; Decker K; Doyle G
    CMAJ; 2000 Oct; 163(9):1133-8. PubMed ID: 11079057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer screening in the Flemish region, Belgium.
    Van Oyen H; Verellen W
    Eur J Cancer Prev; 1994 Jan; 3 Suppl 1():7-12. PubMed ID: 8130728
    [No Abstract]   [Full Text] [Related]  

  • 5. Quality assurance in follow-up and initial treatment for screening mammography programs in 22 countries.
    Klabunde CN; Sancho-Garnier H; Taplin S; Thoresen S; Ohuchi N; Ballard-Barbash R;
    Int J Qual Health Care; 2002 Dec; 14(6):449-61. PubMed ID: 12515331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative analysis of early diagnostic tools for breast cancer].
    Shen SJ; Sun Q; Xu YL; Zhou YD; Guan JH; Mao F; Lin Y; Wang XJ; Han SM
    Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):877-80. PubMed ID: 23291142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Method of tumor detection influences disease-free survival of women with breast carcinoma.
    Senie RT; Lesser M; Kinne DW; Rosen PP
    Cancer; 1994 Mar; 73(6):1666-72. PubMed ID: 8156494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Canadian women's mammography rates since the implementation of mass screening programs.
    De Grasse CE; O'Connor AM; Boulet J; Edwards N; Bryant H; Breithaupt K
    Am J Public Health; 1999 Jun; 89(6):927-9. PubMed ID: 10358690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program.
    Hofvind S; Geller B; Vacek PM; Thoresen S; Skaane P
    Eur J Epidemiol; 2007; 22(7):447-55. PubMed ID: 17594526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ductal carcinoma in situ.
    Loring L; Dershaw DD
    Crit Rev Diagn Imaging; 1997 Dec; 38(6):501-33. PubMed ID: 9442977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiologist interpretive volume and breast cancer screening accuracy in a Canadian organized screening program.
    Théberge I; Chang SL; Vandal N; Daigle JM; Guertin MH; Pelletier E; Brisson J
    J Natl Cancer Inst; 2014 Mar; 106(3):djt461. PubMed ID: 24598715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technical quality control practices in mammography screening programs in 22 countries.
    Hendrick RE; Klabunde C; Grivegnee A; Pou G; Ballard-Barbash R
    Int J Qual Health Care; 2002 Jun; 14(3):219-26. PubMed ID: 12108532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digital mammography screening: average glandular dose and first performance parameters.
    Weigel S; Girnus R; Czwoydzinski J; Decker T; Spital S; Heindel W
    Rofo; 2007 Sep; 179(9):892-5. PubMed ID: 17705112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years.
    Miller AB; To T; Baines CJ; Wall C
    Ann Intern Med; 2002 Sep; 137(5 Part 1):305-12. PubMed ID: 12204013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The current state of the diagnostics of breast diseases in Lombardy].
    Vergnaghi D; Panizza P; Gozzi G
    Radiol Med; 2000 Nov; 100(5):314-20. PubMed ID: 11213407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral breast cancer: early detection with mammography.
    Roubidoux MA; Helvie MA; Lai NE; Paramagul C
    Radiology; 1995 Aug; 196(2):427-31. PubMed ID: 7617856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening mammography in women 40-49 years old.
    Cardenosa G; Eklund GW
    AJR Am J Roentgenol; 1995 May; 164(5):1104-6. PubMed ID: 7717213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.